Citigroup’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,100
Closed -$2.04M 5713
2025
Q1
$2.04M Sell
20,100
-3,400
-14% -$332K ﹤0.01% 2697
2024
Q4
$2.17M Buy
+23,500
New +$2.31M ﹤0.01% 2747

Other funds holding EHC

Citigroup's EHC Position: Q1 2026 in Review

Citigroup increased its Encompass Health (EHC) stake by 10% in Q1 2026, buying an estimated $410K and bringing the position to 43,523 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2098.

Citigroup first reported a position in EHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.58M in Q4 2018. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Citigroup held 43,523 shares of Encompass Health worth $4.21M as of Q1 2026.
  • Citigroup bought 4,000 Encompass Health shares in Q1 2026, an estimated $410K.
  • Encompass Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2098 holding.
  • Citigroup first reported a position in Encompass Health in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Encompass Health position peaked at $7.58M in Q4 2018.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.